Cross-institution positioning
Aug 7, 2026Reduction leaning. 1 accumulating, 1 reducing, 2 exited across 4 comparable institutions.
Source: Schedule 13 researchMYRIAD GENETICS INC
Latest stored close $4.31 as of Oct 9, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Reduction leaning. 1 accumulating, 1 reducing, 2 exited across 4 comparable institutions.
Source: Schedule 13 research2 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsRecent Forms 3/4/5 activity is available, with no non-amendment non-derivative SEC-coded P/S transactions in the rolling 90-day window. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/53 non-amendment material events in the last 90 days; Latest classified evidence: Director or executive change. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue -10.5% YoY; Net income +86.9% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 19% through its reported 52-week range; -46.9% over one year.
Source: Stored historical price seriesFiled Aug 7, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Wheeler Benjamin Richard | FTax/price withholding or payment | Common Stock | 2.6K | $4.01 | Direct | Sep 22, 2026 |
| Sep 16, 2026 | Sikri Vishal | AGrant, award, or other acquisition | Common Stock | 257.7K | $0.00 | Direct | Sep 17, 2026 |
| Sep 3, 2026 | Fox Jennifer Lynne | FTax/price withholding or payment | Common Stock | 4.4K | $3.23 | Direct | Sep 8, 2026 |
| Aug 16, 2026 | Wheeler Benjamin Richard | FTax/price withholding or payment | Common Stock | 8.8K | $3.03 | Direct | Aug 17, 2026 |
| Jun 11, 2026 | Raha Samraat S. | AGrant, award, or other acquisition | Common Stock | 3.5K | $3.94 | Direct | Jun 12, 2026 |
| Jun 11, 2026 | Donnelly Brian J | AGrant, award, or other acquisition | Common Stock | 5.0K | $3.94 | Direct | Jun 12, 2026 |
| Jun 8, 2026 | Kumar Rashmi | SOpen-market or private sale | Common Stock | 15.0K | $4.46 | Direct | Jun 9, 2026 |
| Jun 4, 2026 | Skovronsky Daniel | AGrant, award, or other acquisition | Common Stock | 59.7K | $0.00 | Direct | Jun 5, 2026 |
| Jun 4, 2026 | Newcomer Lee Nisley | AGrant, award, or other acquisition | Common Stock | 59.7K | $0.00 | Direct | Jun 5, 2026 |
| Jun 4, 2026 | Davis Mark Steven | AGrant, award, or other acquisition | Common Stock | 59.7K | $0.00 | Direct | Jun 5, 2026 |
| Jun 4, 2026 | Phanstiel S. Louise | AGrant, award, or other acquisition | Common Stock | 59.7K | $0.00 | Direct | Jun 5, 2026 |
| Jun 4, 2026 | Dreismann Heinrich | AGrant, award, or other acquisition | Common Stock | 59.7K | $0.00 | Direct | Jun 5, 2026 |
| Jun 4, 2026 | Reitan Colleen F | AGrant, award, or other acquisition | Common Stock | 59.7K | $0.00 | Direct | Jun 5, 2026 |
| Jun 4, 2026 | Bisaro Paul | AGrant, award, or other acquisition | Common Stock | 59.7K | $0.00 | Direct | Jun 5, 2026 |
| Jun 4, 2026 | Kumar Rashmi | AGrant, award, or other acquisition | Common Stock | 59.7K | $0.00 | Direct | Jun 5, 2026 |
| Jun 1, 2026 | Jampa Raj | AGrant, award, or other acquisition | Common Stock | 251.9K | $0.00 | Direct | Jun 2, 2026 |
| May 14, 2026 | Bisaro Paul | POpen-market or private purchase | Common Stock | 7.5K | $3.69 | Direct | May 14, 2026 |
| May 1, 2026 | Donnelly Brian J | FTax/price withholding or payment | Common Stock | 56.0K | $4.80 | Direct | May 4, 2026 |
| Apr 14, 2026 | Verratti Mark | FTax/price withholding or payment | Common Stock | 1.1K | $4.91 | Direct | Apr 15, 2026 |
| Apr 14, 2026 | Muzzey Dale | FTax/price withholding or payment | Common Stock | 946 | $4.91 | Direct | Apr 15, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Oct 9, 2026 | 8-K | 5.02, 9.01 | Director or executive change; Financial statements / exhibits | — | Filing |
| Sep 16, 2026 | 8-K | 5.02, 7.01, 9.01 | Director or executive change; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Jul 30, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Jun 23, 2026 | 8-K | 5.02 | Director or executive change | — | Filing |
| Jun 4, 2026 | 8-K | 5.02, 5.07, 9.01 | Director or executive change; Shareholder vote results; Financial statements / exhibits | — | Filing |
| Jun 4, 2026 | S-8 | — | Employee-plan securities registration | Equity | Filing |
| Jun 4, 2026 | S-8 | — | Employee-plan securities registration | Equity | Filing |
| May 5, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Mar 4, 2026 | 424B3 | — | Prospectus filing | Capital-related | Filing |
| Feb 24, 2026 | S-3 | — | Shelf securities registration | Capital-related | Filing |
| Feb 23, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Jan 12, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 30, 2026 | $190.7M | -10.5% |
| Ended Mar 31, 2026 | $200.4M | +2.3% |
| Ended Sep 30, 2025 | $205.7M | -3.6% |
| Ended Jun 30, 2025 | $213.1M | +0.8% |
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 31, 2025 | $824.5M | -1.6% |
| Ended Dec 31, 2024 | $837.6M | +11.2% |
| Ended Dec 31, 2023 | $753.2M | +11.0% |
| Ended Dec 31, 2022 | $678.4M | -1.8% |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| State Street CIK0000093751 | Jun 30, 2026 observed Aug 7, 2026 filed · 38d Initial Schedule 13G | Initial Schedule 13G | 5.0M +561.0K | 5.30% -6.70 pts | $5.71 | $3.26 | $4.31 |
| State Street CIK0000093751 | Mar 31, 2026 observed May 12, 2026 filed · 42d Initial Schedule 13G | Initial Schedule 13G | 4.4M -1.5M | 12.00% 0.00 pts | $4.50 | $4.07 | $4.31 |
| BlackRock CIK0002012383 | Mar 31, 2026 observed Apr 7, 2026 filed · 7d Schedule 13G amendment | Reported reduction | 8.0M -6.1M | 12.00% -3.30 pts | $4.50 | $4.74 | $4.31 |
Compare MYGN with other securities showing similar institutional activity or recent accumulation across several tracked institutions.